ENTITY

Chongkundang Holdings (001630 KS)

4
Analysis
Health CareSouth Korea
Chongkundang Holdings Corporation operates as a holding company. The Company, through its subsidiaries, manufactures pharmaceutical products and medical drugs in the fields of systemic anti-infective, cardiovascular system, alimentary tract, metabolism, and sensory organs.
more
16 Oct 2024 06:05

EQD | KOSPI 200 May Pullback Soon...

Pullbacks on the KOSPI 200 INDEX are currently a buy opportunity,  given the short-selling ban still in place. We predict a short-term WEEKLY...

Logo
147 Views
Share
27 Jan 2020 07:58

Impact of Coronavirus on 30 Key Korean Stocks

In this report, we compare the Coronavirus that is scaring the daylights of China and other countries around the world right now with the MERS...

Logo
385 Views
Share
08 Dec 2016 08:24

MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...

Share
07 Jul 2016 00:13

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...

Logo
3.5k Views
Share
x